H.R. 9693: Patients First Act of 2026
This bill would change how Medicare pays doctors and other clinicians in several ways, with a focus on increasing payment levels, reshaping payment incentives, and changing quality-reporting rules.
Medicare payment updates
The bill would raise Medicare physician payment amounts and change how Medicare updates payments over time. It would also adjust geographic payment formulas so that inflation and local cost differences are reflected differently in some areas.
New primary care payment model
The bill would create a new hybrid monthly payment model for primary care from 2027 through 2031. This would combine a monthly payment structure with other payment elements, instead of relying entirely on the current fee-for-service approach.
Quality and performance program changes
The current MIPS program, which is Medicare’s system for measuring and adjusting clinician payment based on performance, would be renamed POINTS. The bill would also extend incentive payments under this program through 2032.
At the same time, the bill would change how performance adjustments work:
- Practices excluded from certain reporting or participation rules would have their positive payment adjustments reduced by 50%.
- Rules for feedback reports and payment adjustments would be revised.
- Some registry standards would be tightened, including requirements related to data access.
Measure and reporting reforms
The bill would create a task force to reform the measures used to evaluate clinician performance. It would also revise rules around imaging appropriateness measures, which are used to assess whether medical imaging is ordered appropriately.
Alternative payment model changes
The bill would freeze certain payment thresholds used for alternative payment models for a period of time. This would affect when clinicians or groups qualify for some bonus payments or reporting requirements tied to those models.
Budget and fee schedule rules
The bill would also update how Medicare’s physician fee schedule handles budget neutrality and cost updates. In practical terms, this means the law would change how payment increases in one area are offset elsewhere, and how Medicare accounts for changing costs when setting physician payments.
Relevant Companies
None found.
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
31 bill sponsors
-
TrackJohn Joyce
Sponsor
-
TrackBrian Babin
Co-Sponsor
-
TrackNanette Diaz Barragán
Co-Sponsor
-
TrackAmi Bera
Co-Sponsor
-
TrackSheri Biggs
Co-Sponsor
-
TrackGus M. Bilirakis
Co-Sponsor
-
TrackEarl L. "Buddy" Carter
Co-Sponsor
-
TrackHerbert Conaway
Co-Sponsor
-
TrackSuzan K. DelBene
Co-Sponsor
-
TrackMaxine Dexter
Co-Sponsor
-
TrackNeal P. Dunn
Co-Sponsor
-
TrackLizzie Fletcher
Co-Sponsor
-
TrackAndy Harris
Co-Sponsor
-
TrackDiana Harshbarger
Co-Sponsor
-
TrackRobin L. Kelly
Co-Sponsor
-
TrackDarin LaHood
Co-Sponsor
-
TrackGreg Landsman
Co-Sponsor
-
TrackRichard McCormick
Co-Sponsor
-
TrackCarol D. Miller
Co-Sponsor
-
TrackMariannette Miller-Meeks
Co-Sponsor
-
TrackKelly Morrison
Co-Sponsor
-
TrackGregory F. Murphy
Co-Sponsor
-
TrackRobert Onder
Co-Sponsor
-
TrackJimmy Panetta
Co-Sponsor
-
TrackKim Schrier
Co-Sponsor
-
TrackTerri A. Sewell
Co-Sponsor
-
TrackThomas R. Suozzi
Co-Sponsor
-
TrackLori Trahan
Co-Sponsor
-
TrackJefferson Van Drew
Co-Sponsor
-
TrackBeth Van Duyne
Co-Sponsor
-
TrackMarc A. Veasey
Co-Sponsor
Actions
2 actions
| Date | Action |
|---|---|
| Jul. 15, 2026 | Introduced in House |
| Jul. 15, 2026 | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.